XML 59 R49.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions | 1 Months Ended | 6 Months Ended |  |  |
--- | --- | --- | --- | --- | ---
Dec. 31, 2022 | Jun. 30, 2024 | May 13, 2024 | Nov. 21, 2023 | Oct. 02, 2023
Other Commitments [Line Items] |  |  |  |  |
Contractual agreements, minimum term |  | 5 years |  |  |
Sutro Biopharma Inc |  |  |  |  |
Other Commitments [Line Items] |  |  |  |  |
Upfront consideration | $ 22.5 |  |  |  |
Upfront consideration in cash | 10.0 |  |  |  |
Upfront consideration in cash after agreement date | $ 5.0 |  |  |  |
Number of common stock issued (in shares) | 167,780 |  |  |  |
Fair value on date of settlement | $ 8.0 |  |  |  |
Option exercise price in cash | 75.0 |  |  |  |
Additional milestone payments in cash | 60.0 |  |  |  |
Accrued payment |  |  | $ 25.0 | $ 50.0 | $ 5.0
Sutro Biopharma Inc | Common Stock |  |  |  |  |
Other Commitments [Line Items] |  |  |  |  |
Upfront consideration | $ 7.5 |  |  |  |

X
- Definition Accrued payment + References No definition available. + Details
Name: | pcvx_AccruedPayment
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Additional milestone payments in cash. + References No definition available. + Details
Name: | pcvx_AdditionalMilestonePaymentsInCash
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Contractual Agreements, Minimum Term + References No definition available. + Details
Name: | pcvx_ContractualAgreementsMinimumTerm
Namespace Prefix: | pcvx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value on Date of Settlement. + References No definition available. + Details
Name: | pcvx_FairValueOnDateOfSettlement
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Option exercise price in cash. + References No definition available. + Details
Name: | pcvx_OptionExercisePriceInCash
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Upfront consideration. + References No definition available. + Details
Name: | pcvx_UpfrontConsideration
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Upfront consideration in cash. + References No definition available. + Details
Name: | pcvx_UpfrontConsiderationInCash
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Upfront consideration in cash after agreement date. + References No definition available. + Details
Name: | pcvx_UpfrontConsiderationInCashAfterAgreementDate
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_OtherCommitmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=pcvx_SutroBiopharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |